Over the past few decades, the UAE has worked hard to attract top global talent to fill the gaps that its small local population was unable to. While…

Amgen has forged a solid position as one of the world’s largest independent biotechnology companies. With a market capitalisation of some USD 130…

Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish…

Ahmed Moustafa outlines the incredible development of the healthcare ecosystem in the UAE driven by a rapid ramping up of the country's health…

At a time when the country's economy has fallen into a slump with the currency sinking to its lowest level in 16 years, Chinese giant Fosun Pharma…

Founded in 1980 “at the dawn of a biotechnology revolution,” Amgen has held its ground throughout its more than 40-year history with innovative…

David H. Crean, Ph.D., Managing Partner at Cardiff Advisory, provides his insights on the potential impact of the US Federal Trade Commission…

Thanks to its world-renowned networks of medical and academic institutions, the long-standing presence of Big Pharma, and a favourable regulatory…

Amgen's Mohammed Nasser casts his eye on some of the key trends affecting healthcare and the life sciences in the Middle East and Africa, including a…

Gábor Sztaniszláv talks through the global relevance of Belux to Amgen's operations, some of the challenging market access conditions at play -…

As the largest pharma market in MEA in terms of volume and second only behind Saudi in value, Egypt is an increasingly important part of pharma…

As Egypt moves towards universal healthcare coverage for its 100 million-plus population, the country has become the fastest growing pharma market in…